Literature DB >> 7695274

New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.

J C Garrigues1, G Cadet de Fontenay, M D Linas, M Lagente, J P Seguela.   

Abstract

We developed a new in vitro method of evaluating antifungal molecules. Fungal growth was determined by measuring glucose consumption, the only carbon source in a synthetic medium. First, the growth of 12 Aspergillus fumigatus strains was studied. Glucose consumption was an excellent indicator of fungal growth. Second, the partial inhibition of growth was calculated in terms of the 90% or 50% inhibitory concentration for the 12 strains after treatment with itraconazole and amphotericin B. With a 3-day incubation time, the calculated 90% and 50% inhibitory concentrations agreed with those obtained by a macromethod and with those reported in previous publications. In each case the high degrees of efficacy of itraconazole and amphotericin B against A. fumigatus were confirmed. Partial inhibition induced by low concentrations of antifungal agents was quantifiable by this new method.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695274      PMCID: PMC188297          DOI: 10.1128/AAC.38.12.2857

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

Authors:  M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Evaluation of antifungal volatile compounds on the basis of the elongation rate of a single hypha.

Authors:  H Matsuoka; Y Ii; Y Takekawa; T Teraoka
Journal:  Appl Environ Microbiol       Date:  1990-12       Impact factor: 4.792

3.  Chitin assay to estimate the growth of Candida albicans in organs of infected mice.

Authors:  A Rementeria; P Ezkurra; F Hernando; J Ponton; M J Sevilla; R Cisterna
Journal:  J Med Vet Mycol       Date:  1991

4.  European experience with itraconazole in systemic mycoses.

Authors:  M A Viviani; A M Tortorano; A Pagano; G M Vigevani; G Gubertini; S Cristina; M L Assaisso; F Suter; C Farina; B Minetti
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

5.  The in-vitro antifungal spectrum of itraconazole.

Authors:  J Van Cutsem
Journal:  Mycoses       Date:  1989       Impact factor: 4.377

6.  Mannan estimation as a measure of the growth of Candida albicans.

Authors:  I H Pike; E G Evans; J A Carney
Journal:  J Med Vet Mycol       Date:  1991

7.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

8.  Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.

Authors:  F C Odds
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.

Authors:  R Shawar; V Paetznick; Z Witte; L G Ensign; E Anaissie; M LaRocco
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Innovative endpoint determination system for antifungal susceptibility testing of yeasts.

Authors:  R Tellier; M Krajden; G A Grigoriew; I Campbell
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

View more
  4 in total

1.  Reduced virulence of Candida albicans MKC1 mutants: a role for mitogen-activated protein kinase in pathogenesis.

Authors:  R Diez-Orejas; G Molero; F Navarro-García; J Pla; C Nombela; M Sanchez-Pérez
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

2.  Attenuation of virulence and changes in morphology in Candida albicans by disruption of the N-acetylglucosamine catabolic pathway.

Authors:  P Singh; S Ghosh; A Datta
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Conidial viability assay for rapid susceptibility testing of Aspergillus species.

Authors:  S Arunmozhi Balajee; Kieren A Marr
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi.

Authors:  Joseph Meletiadis; Debbie T A te Dorsthorst; Paul E Verweij
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.